Minimal Residual Disease in Melanoma Biology, Detection and Clinical Relevance / edited by U. Reinhold, W. Tilgen.

Knowledge about diagnostic procedures in melanoma has in­ creased rapidly within the past few years. Single tumor cells have been identified in normal tissue such as sentinel lymph nodes, as well as in bone marrow, peripheral blood, and other bodily fluids and cells, by molecular technologies. The i...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Reinhold, U. (Editor), Tilgen, W. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2001.
Edition:1st ed. 2001.
Series:Recent Results in Cancer Research, 158
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.

MARC

LEADER 00000nam a22000005i 4500
001 b3203880
003 MWH
005 20191025021204.0
007 cr nn 008mamaa
008 121227s2001 gw | s |||| 0|eng d
020 |a 9783642595370 
024 7 |a 10.1007/978-3-642-59537-0  |2 doi 
035 |a (DE-He213)978-3-642-59537-0 
050 4 |a E-Book 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
245 1 0 |a Minimal Residual Disease in Melanoma  |h [electronic resource] :  |b Biology, Detection and Clinical Relevance /  |c edited by U. Reinhold, W. Tilgen. 
250 |a 1st ed. 2001. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2001. 
300 |a XII, 268 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Recent Results in Cancer Research,  |x 0080-0015 ;  |v 158 
490 1 |a Springer eBook Collection 
505 0 |a I Biology of Micrometastases and Advances in Methods for Detection -- The Biology of Melanoma Micrometastases -- Disseminated Tumor Cells: Diagnosis, Prognostic Relevance, and Phenotyping -- Nested Quantitative Real Time PCR for Detection of Occult Tumor Cells -- Detection of Micrometastasis Through Tissue-Specific Gene Expression: Its Promise and Problems -- Immunobead-Based Detection and Characterization of Circulating Tumor Cells in Melanoma Patients -- Rapid Enrichment and Detection of Melanoma Cells from PBMC by a New Assay Combining Immunomagnetic Cell Sorting and Immunocytochemical Staining -- II. Detection of Residual Melanoma Cells in the Peripheral Blood and Bone Marrow -- Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Detection of Melanoma-Related Transcripts in the Peripheral Blood and Bone Marrow of Patients with Malignant Melanoma. What Have We Learned? -- The Clinical Utility of Multimarker RT-PCR in the Detection of Occult Metastasis in Patients with Melanoma -- Polymerase Chain Reaction in the Detection of Circulating Tumour Cells in Peripheral Blood of Melanoma Patients -- Facts and Pitfalls in the Detection of Tyrosinase mRNA in the Blood of Melanoma Patients by RT-PCR -- Morphologically Intact Melanoma Cells May Be Detected in Peripheral Blood of Melanoma Patients -- Prognosis of Metastatic Melanoma: No Correlation of Tyrosinase mRNA in Bone Marrow and Survival Time -- III. Detection of Minimal Residual Disease in Sentinel Nodes -- The Predictive Value of the Sentinel Lymph Node in Malignant Melanomas -- Detection of Micrometastasis in Sentinel Lymph Nodes of Patients with Primary Cutaneous Melanoma -- IV. Early Recognition and Monitoring by Serological Markers -- Monitoring Malignant Melanoma with the S-100B Tumour Marker -- Melanoma Inhibitory Activity (MIA), a Serological Marker of Malignant Melanoma -- Quantification of Melanoma-Associated Molecules in Plasma/Serum of Melanoma Patients -- V. Clinical Relevance of Micrometastases Detection -- Molecular Tools in the Detection of Micrometastatic Cancer Cells — Technical Aspects and Clinical Relevance -- The Clinical Relevance of Molecular Staging for Melanoma -- Clinical Significance of PCR-Positive mRNA Markers in Peripheral Blood and Regional Nodes of Malignant Melanoma Patients -- Decrease in Circulating Tumor Cells as an Early Marker of Therapy Effectiveness -- VI. Therapeutic Strategies Against Residual Melanoma Cells -- Utility of Tests for Circulating Melanoma Cells in Identifying Patients Who Develop Recurrent Melanoma -- Active Specific Immunotherapy of Malignant Melanoma and Peptide Mimics of the Human High-Molecular-Weight Melanoma-Associated Antigen -- Autologous Dendritic Cells for Treatment of Advanced Cancer — An Update -- A Novel Strategy in the Elimination of Disseminated Melanoma Cells: Chimeric Receptors Endow T Cells with Tumor Specificity. 
520 |a Knowledge about diagnostic procedures in melanoma has in­ creased rapidly within the past few years. Single tumor cells have been identified in normal tissue such as sentinel lymph nodes, as well as in bone marrow, peripheral blood, and other bodily fluids and cells, by molecular technologies. The introduction of polymerase chain reaction-based methods can be regarded as a prototype of this dramatic development towards molecular approaches in new diagnostic procedures. This fact opens up the possibility of clinical use in patients and of influencing treatment strategies. Considerable discrepancies have been described, how­ ever, in the success rates of these new techniques for the detec­ tion of minimal residual disease in cancer patients. Despite fav­ orable results reported by different groups of investigators, it will take several years to define the clinical and pathophysiological relevance of new diagnostic procedures. The 1st International Symposium "Minimal Residual Disease in Melanoma: Biology, Detection and Clinical Relevance of Microme­ tastases", held in September 1999 in Homburg/Saar, Germany, fo­ cused on recent developments in this particular area of cancer re­ search. The purpose of the meeting was to stimulate discussion and exchange of new data and ideas by renowned international scientists. The aim of this volume is to summarize major topics of basic research and clinical investigations presented by invited experts in this fascinating but still. controversial field of melanoma re­ search. 
590 |a Loaded electronically. 
590 |a Electronic access restricted to members of the Holy Cross Community. 
650 0 |a Cancer research. 
650 0 |a Oncology  . 
650 0 |a Dermatology. 
650 0 |a Molecular biology. 
690 |a Electronic resources (E-books) 
700 1 |a Reinhold, U.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Tilgen, W.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
830 0 |a Recent Results in Cancer Research,  |x 0080-0015 ;  |v 158 
830 0 |a Springer eBook Collection. 
856 4 0 |u https://holycross.idm.oclc.org/login?auth=cas&url=https://doi.org/10.1007/978-3-642-59537-0  |3 Click to view e-book 
907 |a .b3203880x  |b 04-18-22  |c 02-26-20 
998 |a he  |b 02-26-20  |c m  |d @   |e -  |f eng  |g gw   |h 0  |i 1 
912 |a ZDB-2-SME 
912 |a ZDB-2-BAE 
950 |a Medicine (Springer-11650) 
902 |a springer purchased ebooks 
903 |a SEB-COLL 
945 |f  - -   |g 1  |h 0  |j  - -   |k  - -   |l he   |o -  |p $0.00  |q -  |r -  |s b   |t 38  |u 0  |v 0  |w 0  |x 0  |y .i21170447  |z 02-26-20 
999 f f |i 9b78e7a0-ea46-58d1-bc6c-019e74d7738b  |s 6548596c-1496-56e8-b954-edb5fb7ef496 
952 f f |p Online  |a College of the Holy Cross  |b Main Campus  |c E-Resources  |d Online  |e E-Book  |h Library of Congress classification  |i Elec File  |n 1